Veterinary R&D

Now with a richer pipeline of biological and pharmaceutical products, Pfizer Animal Health will expand its worldwide leadership role in animal health research focused on meeting unmet needs in veterinary care.

Pfizer invests an estimated $300 million annually in veterinary R&D from major, global centres in Australia, Belgium, India, Spain, the United Kingdom, and the United States.

Pfizer Animal Health also is building a diverse and innovative portfolio in biopharmaceutics, and emerging diseases. To help find new medicines for animals, hundreds of Pfizer Animal Health researchers in veterinary medicine leverage the work of thousands of Pfizer scientists searching for new human health solutions.

A Business Development & Global Alliances team of medical, scientific and business experts collaborate with external R&D partners, explore new market opportunities, technology or product acquisitions—all in the pursuit of innovation in veterinary medicine.